Ads
related to: lenalidomide revlimid costSCBN.org has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]
Then came the bills for Revlimid, a powerful cancer drug that her doctor said was her best hope for controlling the disease. The first month’s supply cost $11,148; the second, $12,040—and her ...
The high cost of prescription drugs. ... KFF estimates the average out-of-pocket cost to take the cancer drug Revlimid in 2020 was $6,200, for example. Some 1.4 million Part D enrollees paid more ...
Biden said cancer drugs can cost $10,000 to $15,000. ... the five drugs with the highest per capita Part D expenditures in 2021 used by more than 10,000 Part D enrollees — Revlimid, ...
Lenalidomide: Revlimid Small molecule Multiple myeloma. Myelodysplastic syndromes. Celgene: 5,801 821 10 Sofosbuvir: Sovaldi Small molecule Hepatitis C: Gilead Sciences: 5,276 (5,007) 11 Fluticasone propionate/salmeterol: Seretide Advair Small molecule Asthma. Chronic obstructive pulmonary disease. GlaxoSmithKline: 5,227 (778) 12 Rosuvastatin ...
[92] [93] Celgene has sponsored numerous clinical trials with analogues to thalidomide, such as lenalidomide, that are substantially more powerful and have fewer side effects — except for greater myelosuppression. [94] In 2005, Celgene received FDA approval for lenalidomide (Revlimid) as the first commercially useful derivative. Revlimid is ...
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending goes into effect.
Revlimid: lenalidomide (in combination with dexamethasone) treatment of multiple myeloma patients who have received at least one prior therapy 06-29-2006
Ads
related to: lenalidomide revlimid costSCBN.org has been visited by 10K+ users in the past month